Integrating Narcissus-derived galanthamine production into traditional upland farming systems

Authors:

Abstract
Alzheimer’s disease (AD) is a disorder associated with progressive degeneration of memory and cognitive function. Galantamine is a licenced treatment for AD but supplies of the plant alkaloid that it is produced from, galanthamine, are limited. This three-year system study tested the potential to combineNarcissus-derived galanthamine production with grassland-based ruminant production. Replicate plots of permanent pasture were prepared with and without bulbs ofNarcissus pseudonarcissussown as lines into the sward. Two different fertiliser regimes were imposed. The above-ground green biomass ofN. pseudonarcissuswas harvested in early spring and the galanthamine yield determined. In the second harvest year a split-plot design was implemented with lines ofN. pseudonarcissuscut annually and biennially. All plots were subsequently grazed by ewes and lambs and animal performance recorded. Incorporation ofN. pseudonarcissusinto grazed permanent pasture had no detrimental effects on the health or performance of the sheep which subsequently grazed the pasture. There was no consistency to the effects of fertiliser rates on galanthamine yields. There was no difference in overall galanthamine yield ifN. pseudonarcissuswas cut biennially (1.64 vs. 1.75 kg galanthamine/ha for annual combined vs biennial cuts respectively; s.e.d = 0.117 kg galanthamine/ha; ns). This study verified the feasibility of a dual cropping approach to producing plant-derived galanthamine.
Funding Information
  • Biotechnology and Biological Sciences Research Council (BB/M027120/1)
  • Innovate UK

This publication has 31 references indexed in Scilit: